Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 14, 2020 (6 years ago)

Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent drug.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoedl Ct. Little Rock, AR 72205 Bar Code 70004093232

Drug: Vasopressin

Recalling firm
SCA Pharmaceuticals, Inc.
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0171-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Vasopressin recalls

See all
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9647-12 D-0819-2026
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9640-12 D-0811-2026
Class II · Moderate risk

Vasopressin Injection

Subpotent product in addition to having out-of-specification results for impurities.

Terminated Wrong potency / content American Regent, Inc. NDC 0517-1030-01 D-0507-2024

Other recalls by SCA Pharmaceuticals, Inc.

All 2020 recalls